Stay updated on EMPIRE CF: CTX-4430 Clinical Trial
Sign up to get notified when there's something new on the EMPIRE CF: CTX-4430 Clinical Trial page.

Latest updates to the EMPIRE CF: CTX-4430 Clinical Trial page
- Check2 days agoChange DetectedThe clinical trial record is now displayed, including the study design, eligibility criteria, treatment arms, outcome measures, participating locations, and study documents.SummaryDifference81%

- Check9 days agoChange DetectedThe footer revision identifier was updated from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check16 days agoChange DetectedA sitewide NIH notice appears above the ClinicalTrials.gov study-record error page, announcing a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check23 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check30 days agoChange DetectedThe site’s footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check51 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content. This blocks access to the study details and navigation on that page.SummaryDifference18%

Stay in the know with updates to EMPIRE CF: CTX-4430 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EMPIRE CF: CTX-4430 Clinical Trial page.